EnVVeno Historical Financial Ratios

NVNO Stock  USD 2.79  0.07  2.45%   
EnVVeno Medical is recently reporting on over 90 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 68.15 will help investors to properly organize and evaluate enVVeno Medical Corp financial condition quickly.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About EnVVeno Financial Ratios Analysis

enVVeno Medical CorpFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate EnVVeno Medical investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on EnVVeno financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across EnVVeno Medical history.

EnVVeno Medical Financial Ratios Chart

At this time, EnVVeno Medical's Payables Turnover is very stable compared to the past year. As of the 19th of December 2024, Research And Ddevelopement To Revenue is likely to grow to 66.73, while Days Sales Outstanding is likely to drop 68.15.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On EquityOperating Cycle
Cash Conversion Cycle

Price To Sales Ratio

Price to Sales Ratio is figured by comparing enVVeno Medical Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on EnVVeno Medical sales, a figure that is much harder to manipulate than other enVVeno Medical Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is enVVeno Medical Corp dividend as a percentage of EnVVeno Medical stock price. enVVeno Medical Corp dividend yield is a measure of EnVVeno Medical stock productivity, which can be interpreted as interest rate earned on an EnVVeno Medical investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Book Value Per Share

The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.

Operating Cash Flow Per Share

A measure of the cash generated from a company's normal business operations per share, indicating how much cash is generated from a company's business operations on a per-share basis.
Most ratios from EnVVeno Medical's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into enVVeno Medical Corp current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, EnVVeno Medical's Payables Turnover is very stable compared to the past year. As of the 19th of December 2024, Research And Ddevelopement To Revenue is likely to grow to 66.73, while Days Sales Outstanding is likely to drop 68.15.
 2023 2024 (projected)
Payables Turnover1.281.34
Days Of Inventory On Hand36.8532.76

EnVVeno Medical fundamentals Correlations

0.67-0.430.63-0.630.230.63-0.080.671.00.23-0.37-0.380.38-0.380.320.960.41-0.370.58-0.33-0.37-0.510.25-0.24-0.37
0.67-0.760.62-0.87-0.530.84-0.041.00.61-0.52-0.81-0.3-0.39-0.30.290.760.69-0.740.5-0.68-0.74-0.580.48-0.73-0.74
-0.43-0.76-0.030.540.56-0.690.16-0.76-0.410.550.440.120.470.12-0.11-0.47-0.420.67-0.280.580.670.43-0.390.360.67
0.630.62-0.03-0.640.020.540.00.620.580.02-0.52-0.310.11-0.310.320.710.74-0.350.56-0.32-0.35-0.430.29-0.48-0.35
-0.63-0.870.54-0.640.51-0.73-0.06-0.87-0.580.510.850.150.320.15-0.09-0.72-0.680.62-0.450.60.620.33-0.490.780.62
0.23-0.530.560.020.51-0.43-0.16-0.530.291.00.64-0.180.92-0.180.070.07-0.40.580.110.580.580.12-0.440.670.58
0.630.84-0.690.54-0.73-0.430.230.840.58-0.43-0.550.01-0.240.010.380.740.71-0.770.22-0.76-0.77-0.680.59-0.45-0.77
-0.08-0.040.160.0-0.06-0.160.23-0.04-0.09-0.2-0.070.220.040.220.460.03-0.14-0.23-0.75-0.43-0.23-0.390.3-0.03-0.23
0.671.0-0.760.62-0.87-0.530.84-0.040.61-0.52-0.81-0.3-0.39-0.30.290.760.69-0.740.5-0.68-0.74-0.580.48-0.73-0.74
1.00.61-0.410.58-0.580.290.58-0.090.610.28-0.32-0.370.43-0.370.290.940.35-0.320.57-0.28-0.32-0.470.2-0.18-0.32
0.23-0.520.550.020.511.0-0.43-0.2-0.520.280.64-0.190.91-0.190.050.06-0.380.590.140.60.590.13-0.450.670.59
-0.37-0.810.44-0.520.850.64-0.55-0.07-0.81-0.320.640.020.530.020.04-0.46-0.480.48-0.390.480.480.18-0.330.980.48
-0.38-0.30.12-0.310.15-0.180.010.22-0.3-0.37-0.190.02-0.241.0-0.62-0.42-0.080.26-0.240.190.260.52-0.14-0.050.26
0.38-0.390.470.110.320.92-0.240.04-0.390.430.910.53-0.24-0.240.260.29-0.280.280.030.250.28-0.1-0.070.610.28
-0.38-0.30.12-0.310.15-0.180.010.22-0.3-0.37-0.190.021.0-0.24-0.62-0.42-0.080.26-0.240.190.260.52-0.14-0.050.26
0.320.29-0.110.32-0.090.070.380.460.290.290.050.04-0.620.26-0.620.450.11-0.52-0.3-0.58-0.52-0.920.450.14-0.52
0.960.76-0.470.71-0.720.070.740.030.760.940.06-0.46-0.420.29-0.420.450.56-0.590.51-0.56-0.59-0.650.49-0.32-0.59
0.410.69-0.420.74-0.68-0.40.71-0.140.690.35-0.38-0.48-0.08-0.28-0.080.110.56-0.630.52-0.54-0.63-0.360.55-0.45-0.63
-0.37-0.740.67-0.350.620.58-0.77-0.23-0.74-0.320.590.480.260.280.26-0.52-0.59-0.63-0.030.971.00.74-0.910.381.0
0.580.5-0.280.56-0.450.110.22-0.750.50.570.14-0.39-0.240.03-0.24-0.30.510.52-0.030.13-0.030.11-0.08-0.38-0.03
-0.33-0.680.58-0.320.60.58-0.76-0.43-0.68-0.280.60.480.190.250.19-0.58-0.56-0.540.970.130.970.76-0.910.380.97
-0.37-0.740.67-0.350.620.58-0.77-0.23-0.74-0.320.590.480.260.280.26-0.52-0.59-0.631.0-0.030.970.74-0.910.381.0
-0.51-0.580.43-0.430.330.12-0.68-0.39-0.58-0.470.130.180.52-0.10.52-0.92-0.65-0.360.740.110.760.74-0.590.060.74
0.250.48-0.390.29-0.49-0.440.590.30.480.2-0.45-0.33-0.14-0.07-0.140.450.490.55-0.91-0.08-0.91-0.91-0.59-0.24-0.91
-0.24-0.730.36-0.480.780.67-0.45-0.03-0.73-0.180.670.98-0.050.61-0.050.14-0.32-0.450.38-0.380.380.380.06-0.240.38
-0.37-0.740.67-0.350.620.58-0.77-0.23-0.74-0.320.590.480.260.280.26-0.52-0.59-0.631.0-0.030.971.00.74-0.910.38
Click cells to compare fundamentals

EnVVeno Medical Account Relationship Matchups

EnVVeno Medical fundamentals Accounts

201920202021202220232024 (projected)
Ptb Ratio8.761.571.051.481.371.44
Book Value Per Share1.575.56.273.453.763.94
Free Cash Flow Yield(0.72)(0.7)(0.21)(0.27)(0.3)(0.31)
Operating Cash Flow Per Share(9.35)(5.94)(1.36)(1.39)(1.53)(1.61)
Capex To Depreciation0.920.470.810.220.06040.0574
Pb Ratio8.761.571.051.481.371.44
Free Cash Flow Per Share(9.93)(6.08)(1.41)(1.4)(1.54)(1.61)
Roic(6.68)(1.2)(0.3)(0.63)(0.54)(0.57)
Net Income Per Share(12.1)(6.91)(1.87)(2.16)(1.91)(2.01)
Cash Per Share2.077.236.313.483.772.75
Pocfratio(1.47)(1.46)(4.83)(3.67)(3.35)(3.19)
Capex To Operating Cash Flow(0.0617)(0.0235)(0.0311)(0.007363)(0.00175)(0.001662)
Pfcf Ratio(1.38)(1.42)(4.68)(3.64)(3.35)(3.18)
Income Quality0.770.840.720.630.80.55
Roe(7.7)(1.26)(0.3)(0.63)(0.51)(0.53)
Ev To Operating Cash Flow(1.39)(0.35)(0.38)(3.49)(3.24)(3.07)
Pe Ratio(1.14)(1.25)(3.53)(2.36)(2.69)(2.82)
Return On Tangible Assets(2.22)(0.85)(0.28)(0.58)(0.48)(0.51)
Ev To Free Cash Flow(1.31)(0.35)(0.37)(3.46)(3.23)(3.07)
Earnings Yield(0.88)(0.8)(0.28)(0.42)(0.37)(0.39)
Net Debt To E B I T D A0.06470.973.150.120.08870.0842
Current Ratio0.763.034.8325.7834.2335.94
Tangible Book Value Per Share1.575.56.273.453.763.94
Graham Number20.6729.2216.2212.9612.7112.07
Shareholders Equity Per Share1.575.56.273.453.763.94
Capex Per Share0.580.140.04240.01020.0026830.002549
Graham Net Net(1.8)4.565.933.223.583.75

Pair Trading with EnVVeno Medical

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if EnVVeno Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnVVeno Medical will appreciate offsetting losses from the drop in the long position's value.

Moving against EnVVeno Stock

  0.57ECOR Electrocore LLC Upward RallyPairCorr
  0.55MD Mednax IncPairCorr
  0.49VREX Varex Imaging CorpPairCorr
  0.48OM Outset MedicalPairCorr
  0.44DOCS DoximityPairCorr
The ability to find closely correlated positions to EnVVeno Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace EnVVeno Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back EnVVeno Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling enVVeno Medical Corp to buy it.
The correlation of EnVVeno Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as EnVVeno Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if enVVeno Medical Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for EnVVeno Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether enVVeno Medical Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of EnVVeno Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Envveno Medical Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Envveno Medical Corp Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in enVVeno Medical Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of EnVVeno Medical. If investors know EnVVeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about EnVVeno Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.29)
Return On Assets
(0.37)
Return On Equity
(0.59)
The market value of enVVeno Medical Corp is measured differently than its book value, which is the value of EnVVeno that is recorded on the company's balance sheet. Investors also form their own opinion of EnVVeno Medical's value that differs from its market value or its book value, called intrinsic value, which is EnVVeno Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because EnVVeno Medical's market value can be influenced by many factors that don't directly affect EnVVeno Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between EnVVeno Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if EnVVeno Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, EnVVeno Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.